Molecular immunotherapy for oral cancer based on the host immunity diagnosis.
Project/Area Number |
25293412
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Partial Multi-year Fund |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Ehime University |
Principal Investigator |
Hamakawa Hiroyuki 愛媛大学, 医学(系)研究科(研究院), 教授 (20127905)
|
Co-Investigator(Kenkyū-buntansha) |
Nakashiro Koh-ichi 愛媛大学, 大学院医学系研究科, 准教授 (90314880)
Goda Hiroyuki 愛媛大学, 医学部付属病院, 講師 (00464371)
|
Co-Investigator(Renkei-kenkyūsha) |
Okamoto Masato 北里大学, 薬学部, 特任教授 (10243718)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥17,550,000 (Direct Cost: ¥13,500,000、Indirect Cost: ¥4,050,000)
Fiscal Year 2015: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2014: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥7,410,000 (Direct Cost: ¥5,700,000、Indirect Cost: ¥1,710,000)
|
Keywords | 口腔癌 / 免疫療法 / バイオマーカー / IL-6 / 癌間質 / PD-L |
Outline of Final Research Achievements |
Recently immunotherapy are promising cancer therapy. However, the biomarker evaluating immunological condition is not established. In the present study, We have identified IL-6 and 8 as a critical biomarker in oral cancer. We showed that the serum IL-6 level tended to negatively correlate with favorable outcome. And IL-6 has important roles in cancer progression via angiogenesis. IL-8 may be involved in poor clinical outcomes via generation of CD163-positive M2 macrophages. These findings obtained from this study lead to development of personalized immunochemotherapy for oral cancer patients.
|
Report
(4 results)
Research Products
(10 results)
-
-
[Journal Article] Prognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma2014
Author(s)
Fujita Y, Okamoto M, Goda H, Tano T, Nakashiro K, Sugita A, Fujita T, Koido S, Homma S, Kawakami Y, Hamakawa H.
-
Journal Title
PLoS ONE
Volume: 9
Issue: 12
Pages: e110378-e110378
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Immuno-Chemoradiotherapy for Patients with Oral Squamous Cell Carcinoma: Augmentation of OK-432-Induced Helper T-Cell 1 Response by 5-FU and X-Ray Irradiation.2013
Author(s)
Tano T, Okamoto M, Kan S, Bando T, Goda H, Nakashiro K, Shimodaira S, Koido S, Homma S, Fujita T, Sato M, Yamashita N, Hamakawa H, Kawakami Y.
-
Journal Title
Neoplasia
Volume: 15(7)
Pages: 805-814
Related Report
Peer Reviewed
-
-
-
-
-
-
-